Synthesis of a New trans-A2B2 Phthalocyanine Motif
5,6-Dicyano-2-phenyl-1-propylbenzimidazole (6b). A 25 mL
round-bottom flask was charged with 3 (316 mg, 2.00 mmol), NMP
(10 mL), benzaldehyde, (202 µL, 2.00 mmol), and a magnetic
stirring bar. The flask was fitted with a Hickman still, placed in an
oil bath heated to 120 °C, and stirred for 1 h. Then FeCl3‚6H2O
(27 mg, 0.10 mmol) was added to the reaction vessel, and oxygen
was bubbled through the mixture as it was heated and stirred for
an additional 20 h. The reaction mixture was then removed from
heat and added to ethyl acetate. The mixture was washed three
times with water, then with brine, dried over Na2SO4, filtered, and
concentrated to dryness. The residue (458 mg, 1.88 mmol) was
dissolved in NMP (2 mL) and heated to 80 °C. Then DBU (280
µL, 1.88 µmol) was added, the mixture was stirred for 2 min, and
iodopropane (183 µL, 1.88 mmol) was added. After 20 min, the
mixture was treated with a second round of DBU and iodopropane,
and after an additional 20 min, a third round of reagents was added.
After a final 20 min of heating, the mixture was transferred to ethyl
acetate and washed three times with water, then with brine, dried
over Na2SO4, filtered, concentrated to dryness, and chromatographed
(silica, CH2Cl2, 3% ethyl acetate, 1% 2-propanol), yielding an off-
white solid (253 mg, 44%): mp 183-185 °C; 1H NMR (CDCl3) δ
0.90 (t, J ) 7.6 Hz, 2H), 1.81-1.92 (m, 2H), 4.29 (t, J ) 7.6 Hz,
2H), 7.56-7.62 (m, 3H), 7.70-7.73 (m, 2H), 7.89 (s, 1H), 8.20
(s, 1H); 13C NMR (CDCl3) δ 11.4, 23.5, 47.3, 108.7, 109.0, 116.7,
116.8, 116.9, 126.6, 128.8, 129.5, 129.5, 131.4, 137.8, 145.4, 159.5;
FAB-MS obsd 287.1302, calcd 287.1297 [(M + H)+; M )
C18H14N4].
5,6-Dicyano-2-(4-iodophenyl)-1-propylbenzimidazole (6c). A
25 mL round-bottom flask was charged with 3 (340 mg, 2.15
mmol), NMP (10 mL), 4-iodobenzaldehyde, (499 mg, 2.15 mmol),
and a magnetic stirring bar. The flask was fitted with a Hickman
still, placed in an oil bath heated to 120 °C, and stirred for 1 h.
Then FeCl3‚6H2O (29 mg, 0.11 mmol) was added to the reaction
vessel, and oxygen was bubbled through the mixture as it was
heated and stirred for an additional 24 h. The reaction mixture was
then removed from heat and added to ethyl acetate. The ethyl acetate
solution was washed three times with water, then washed with brine,
dried over Na2SO4, filtered, and concentrated to dryness. The residue
(603 mg, 1.63 mmol) was suspended in CH3CN and heated to 80
°C. Then DBU (243 µL, 1.63 µmol) was added, the mixture was
stirred for 2 min, and iodopropane (159 µL, 1.63 mmol) was added.
After 20 min, the mixture was treated with a second round of DBU
and iodopropane, and after an additional 20 min, a third round of
reagents was added. After a final 20 min of heating, the mixture
was transferred to ethyl acetate and washed three times with water,
followed by brine. After the organic layer was dried over Na2SO4,
the mixture was filtered, concentrated to dryness, and chromato-
graphed (silica, CHCl3, 5% ethyl acetate), giving a white solid (440
mg, 50%): mp 208-209 °C; 1H NMR (CDCl3) δ 0.91 (t, J ) 7.6
Hz, 3H), 1.80-1.91 (m, 2H) 4.26 (t, J ) 7.6 Hz, 2H), 7.46 (d, J )
8.0 Hz, 2H), 7.87 (s, 1H), 7.95 (d, J ) 8.0 Hz, 2H), 8.22 (s, 1H);
13C NMR (CDCl3) δ 11.4, 23.6, 47.4, 98.4, 109.0, 109.3, 116.55,
116.62, 116.9, 126.7, 128.2, 130.9, 137.8, 138.7, 145.3, 158.4. Anal.
Calcd for C18H13IN4: C, 52.45; H, 3.18; N, 13.59. Found: C, 52.40;
H, 3.06; N, 13.40.
Tetrakis(2-tridec-7-yl-1-propylbenzimidazo[5,6-b:5′,6′-g:5′′,6′′-
l:5′′′,6′′′-q])porphyrazine (Fb-7). A 5 mL reaction vial was charged
with 6a (150 mg, 382 µmol), pentanol (1.90 mL), and a magnetic
stirring bar. The vial was capped and heated in a heating block set
at 145 °C, and then DBU (57 µL, 382 µmol) was added. Heating
and stirring continued for 18 h. The vial was then removed from
heat, and upon cooling to room temperature, the mixture was diluted
with 18 mL of MeOH, and then centrifuged. The supernatant was
removed, and the pellet was resuspended in MeOH and centrifuged
again. After the supernatant was removed a second time, the pellet
was redissolved in THF (2 mL) and precipitated by addition of
MeOH (18 mL). The mixture was centrifuged, and upon removal
of the supernatant, the pellet was dried in vacuo, revealing a green
solid (17 mg, 11%): 1H NMR (THF-d8) δ 0.30-0.50 (br s, 2H),
0.80-1.00 (m, 24H), 1.17-1.60 (m, 76H), 1.80-2.10 (m, 8H),
2.10-2.42 (m, 16H), 3.10-3.25 (m, 2H), 3.30-3.40 (m, 2H),
4.30-4.50 (m, 4H), 4.70-4.84 (m, 4H), 9.30-9.70 (m, 8H); LD-
MS obsd 1570.8; FAB-MS obsd 1571.2178, calcd 1571.1916
(C100H146N16); λabs (nm) 309, 342, 376, 640, 676, 713, 737; λem
742 nm; Φf ) 0.59.
Preparation of Fb-7 Using Lithium Pentoxide. A 5 mL
reaction vial was charged with a magnetic stirring bar, pentanol
(1.0 mL), and Li ribbon (23 mg, 3.3 mmol). The vial was capped,
vented, and warmed to 90 °C. After all of the Li was consumed
(40 min), the vial was removed from heat and allowed to cool to
room temperature. Then a sample of 6a (150 mg, 0.382 mmol) in
pentanol (1.0 mL) was added, and the vial was capped and heated
to 140 °C for 4 h. The vial was then removed from heat, and upon
cooling to room temperature, the mixture was diluted with 18 mL
of MeOH (2% CH3CO2H) and centrifuged, and the supernatant was
removed. The pellet was resuspended in MeOH and centrifuged
again. After the supernatant was removed a second time, the pellet
was redissolved in THF (2 mL) and precipitated by addition of
MeOH (18 mL). The mixture was centrifuged, and upon removal
of the supernatant, the pellet was dried in vacuo, giving a green
solid (74 mg, 49%). Characterization data were consistent with the
material produced from the DBU-mediated reaction (vide supra).
Tetrakis(2-tridec-7-yl-1-propylbenzimidazo[5,6-b:5′,6′-g:5′′,6′′-
l:5′′′,6′′′-q])porphyrazinatomagnesium(II) (Mg-7). A 5 mL reac-
tion vial was charged with 6a (150 mg, 382 µmol), MgCl2 (13 mg,
96 µmol), pentanol (1.90 mL), and a magnetic stirring bar. The
vial was capped and heated in a heating block set at 145 °C, and
then DBU (57 µL, 382 µmol) was added. Heating and stirring
continued for 18 h. The vial was then removed from heat, and upon
cooling to room temperature, the mixture was diluted with 16 mL
of MeOH and 2 mL of water and then centrifuged. The supernatant
was removed, and the pellet was resuspended in MeOH/water (8:
1) and centrifuged again. After the supernatant was removed a
second time, the pellet was redissolved in THF (2 mL) and
precipitated by addition of MeOH (16 mL) and water (2 mL). The
mixture was centrifuged, and upon removal of the supernatant, the
pellet was dried in vacuo, giving a green solid (41 mg, 27%): 1H
NMR (THF-d8) δ 0.82-0.96 (m, 24H), 1.16-1.58 (m, 76H), 1.87-
2.02 (m, 8H), 2.18-2.36 (m, 16H), 3.24-3.34 (m, 4H), 4.66-
4.74 (m, 8H), 9.40 (s, 2H), 9.47 (s, 2H), 9.65 (s, 2H), 9.68 (s, 2H);
LD-MS obsd 1592.7; FAB-MS obsd 1593.1650, calcd 1593.1610
(C100H144MgN16); λabs (nm) 310, 363, 640, 680, 713; λem 720 nm;
Φf ) 0.69.
5,6-Dicyano-2-(4-(triisopropylsilylethynyl)phenyl)-1-propyl-
benzimidazole (6d). The same procedure was followed as for 6a,
with the following quantities: 5d (763 mg, 1.79 mmol), NMP (10
mL), DBU (267 µL, 1.79 mmol per dose), and iodopropane (175
µL, 1.79 mmol per dose). The product was isolated by chroma-
tography (silica, CHCl3) as a colorless solid (506 mg, 61%): mp
Tetrakis(2-tridec-7-yl-1-propylbenzimidazo[5,6-b:5′,6′-g:5′′,6′′-
l:5′′′,6′′′-q])porphyrazinatozinc(II) (Zn-7). A 5 mL reaction vial
was charged with 6a (150 mg, 382 µmol) and a magnetic stirring
bar. The vial was then introduced into a glovebox under argon
atmosphere, and ZnCl2 (13 mg, 96 µmol) was added. The vial was
capped and removed from the glovebox, and pentanol (1.90 mL)
was added. The vial was heated to 140 °C in a heating block, and
then DBU (57 µL, 382 µmol) was added. The temperature of the
heating block was raised to 145 °C and continued for 18 h. The
vial was then removed from heat, and upon cooling to room
temperature, the mixture was diluted with 16 mL of MeOH and 2
1
242-243 °C; H NMR (acetone-d6) δ 0.89 (t, J ) 7.2 Hz, 3H),
1.17-1.19 (m, 21H), 1.86-1.96 (m, 2H), 4.53 (t, J ) 7.6 Hz, 2H),
7.75 (d, J ) 8.0 Hz, 2H), 7.91 (d, J ) 8.0 Hz, 2H), 8.36 (s, 1H),
8.50 (s, 1H); 13C NMR (acetone-d6) δ 10.5, 11.3, 18.4, 23.2, 47.1,
93.1, 106.6, 108.1, 108.3, 116.8, 116.9, 118.3, 125.8, 126.3, 129.6,
129.9, 132.5, 138.5, 145.4, 158.4. Anal. Calcd for C29H34N4Si: C,
74.63; H, 7.34; N, 12.01. Found: C, 74.75; H, 7.32; N, 12.01.
J. Org. Chem, Vol. 71, No. 9, 2006 3353